• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估乳腺癌的风险沟通:连续测量患者的知识是否优于分类测量?

Assessing risk communication in breast cancer: are continuous measures of patient knowledge better than categorical?

机构信息

University of California, San Francisco, CA 94118, United States.

出版信息

Patient Educ Couns. 2009 Jul;76(1):106-12. doi: 10.1016/j.pec.2008.11.012. Epub 2009 Jan 1.

DOI:10.1016/j.pec.2008.11.012
PMID:19118973
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2763188/
Abstract

OBJECTIVE

To compare the performance of categorical and continuous measures of patient knowledge in the context of risk communication about breast cancer, in terms of statistical and clinical significance as well as efficiency.

METHODS

Twenty breast cancer patients provided estimates of 10-year mortality risk before and after their oncology visit. The oncologist reviewed risk estimates from Adjuvant!, a well-validated and commonly used prognostic model. Using the Adjuvant! estimates as a gold standard, we calculated how accurate the patient estimates were before and after the visit. We used three novel continuous measures of patient accuracy, the absolute bias, Brier, and Kullback-Leibler scores, and compared them to a categorical measure in terms of sensitivity to intervention effects. We also calculated the sample size required to replicate the primary study using the categorical and continuous measures, as a means of comparing efficiency.

RESULTS

In this sample, the Kullback-Leibler measure was most sensitive to the intervention effects (p=0.004), followed by Brier and absolute bias (both p=0.011), and finally the categorical measure (0.125). The sample size required to replicate the primary study was 18 for the Kullback-Leibler measure, 23 for absolute bias and Brier, and 37 for the categorical measure.

CONCLUSIONS

The continuous measures led to more efficient sample sizes and to rejection of the null hypothesis of no intervention effect. However, the difference in sensitivity of the continuous measures was not statistically significant, and the performance of the categorical measure depends on the researcher's categorical cutoff for accuracy. Continuous measures of patient accuracy may be more sensitive and efficient, while categorical measures may be more clinically relevant.

PRACTICE IMPLICATIONS

Researchers and others interested in assessing the accuracy of patient knowledge should weigh the trade-offs between clinical relevance and statistical significance while designing or evaluating risk communication studies.

摘要

目的

在乳腺癌风险沟通的背景下,比较类别和连续测量患者知识的表现,从统计学和临床意义以及效率方面进行比较。

方法

20 名乳腺癌患者在肿瘤就诊前和就诊后提供了 10 年死亡率风险的估计。肿瘤医生审查了 Adjuvant!的风险估计值,这是一种经过良好验证和广泛使用的预后模型。使用 Adjuvant!的估计值作为金标准,我们计算了患者就诊前后的估计值有多准确。我们使用三种新颖的连续测量患者准确性的方法,即绝对偏差、Brier 和 Kullback-Leibler 分数,并将它们与类别测量方法进行比较,以了解它们对干预效果的敏感性。我们还计算了使用类别和连续测量方法复制主要研究所需的样本量,作为比较效率的一种手段。

结果

在本样本中,Kullback-Leibler 测量方法对干预效果最敏感(p=0.004),其次是 Brier 和绝对偏差(均 p=0.011),最后是类别测量方法(0.125)。复制主要研究所需的样本量为 Kullback-Leibler 测量方法 18 个,绝对偏差和 Brier 测量方法 23 个,类别测量方法 37 个。

结论

连续测量方法导致了更有效的样本量,并拒绝了干预效果无差异的零假设。然而,连续测量方法的敏感性差异没有统计学意义,类别测量方法的性能取决于研究人员对准确性的类别截止值。患者准确性的连续测量方法可能更敏感和有效,而类别测量方法可能更具临床意义。

实践意义

研究人员和其他对评估患者知识准确性感兴趣的人在设计或评估风险沟通研究时,应该权衡临床相关性和统计学意义之间的权衡。

相似文献

1
Assessing risk communication in breast cancer: are continuous measures of patient knowledge better than categorical?评估乳腺癌的风险沟通:连续测量患者的知识是否优于分类测量?
Patient Educ Couns. 2009 Jul;76(1):106-12. doi: 10.1016/j.pec.2008.11.012. Epub 2009 Jan 1.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Oncologist use of the Adjuvant! model for risk communication: a pilot study examining patient knowledge of 10-year prognosis.肿瘤学家对辅助治疗!模型用于风险沟通的应用:一项检验患者对10年预后了解情况的试点研究。
BMC Cancer. 2009 Apr 28;9:127. doi: 10.1186/1471-2407-9-127.
4
Are patients getting the "gist" in risk communication? Patient understanding of prognosis in breast cancer treatment.患者在风险沟通中是否理解了“要点”?乳腺癌治疗中患者对预后的理解。
J Cancer Educ. 2009;24(3):194-9. doi: 10.1080/08858190902876452.
5
Adult patient access to electronic health records.成年患者获取电子健康记录。
Cochrane Database Syst Rev. 2021 Feb 26;2(2):CD012707. doi: 10.1002/14651858.CD012707.pub2.
6
Small class sizes for improving student achievement in primary and secondary schools: a systematic review.小班教学对提高中小学学生成绩的影响:一项系统综述。
Campbell Syst Rev. 2018 Oct 11;14(1):1-107. doi: 10.4073/csr.2018.10. eCollection 2018.
7
Decision aids for people facing health treatment or screening decisions.为面临医疗治疗或筛查决策的人们提供的决策辅助工具。
Cochrane Database Syst Rev. 2017 Apr 12;4(4):CD001431. doi: 10.1002/14651858.CD001431.pub5.
8
Interventions for improving the adoption of shared decision making by healthcare professionals.提高医疗保健专业人员采用共同决策的干预措施。
Cochrane Database Syst Rev. 2010 May 12(5):CD006732. doi: 10.1002/14651858.CD006732.pub2.
9
10
Interventions for raising breast cancer awareness in women.提高女性乳腺癌意识的干预措施。
Cochrane Database Syst Rev. 2017 Feb 10;2(2):CD011396. doi: 10.1002/14651858.CD011396.pub2.

引用本文的文献

1
Genomic insights for personalised care in lung cancer and smoking cessation: motivating at-risk individuals toward evidence-based health practices.肺癌个性化护理与戒烟的基因组学见解:激励高危个体采取循证健康行为。
EBioMedicine. 2024 Dec;110:105441. doi: 10.1016/j.ebiom.2024.105441. Epub 2024 Nov 8.
2
Does use of the adjuvant! model influence use of adjuvant therapy through better risk communication?辅助! 模型的使用是否通过更好的风险沟通影响辅助治疗的使用?
J Natl Compr Canc Netw. 2011 Jul 1;9(7):707-12. doi: 10.6004/jnccn.2011.0061.
3
Oncologist use of the Adjuvant! model for risk communication: a pilot study examining patient knowledge of 10-year prognosis.肿瘤学家对辅助治疗!模型用于风险沟通的应用:一项检验患者对10年预后了解情况的试点研究。
BMC Cancer. 2009 Apr 28;9:127. doi: 10.1186/1471-2407-9-127.

本文引用的文献

1
Population-based validation of the prognostic model ADJUVANT! for early breast cancer.基于人群的早期乳腺癌预后模型ADJUVANT! 的验证
J Clin Oncol. 2005 Apr 20;23(12):2716-25. doi: 10.1200/JCO.2005.06.178.
2
Decision aids for people facing health treatment or screening decisions.为面临医疗治疗或筛查决策的人们提供的决策辅助工具。
Cochrane Database Syst Rev. 2003(2):CD001431. doi: 10.1002/14651858.CD001431.
3
A tailored intervention to aid decision-making about hormone replacement therapy.一种旨在辅助激素替代疗法决策的定制化干预措施。
Am J Public Health. 2002 Jul;92(7):1112-4. doi: 10.2105/ajph.92.7.1112.
4
A randomized trial of a computerized versus an audio-booklet decision aid for women considering post-menopausal hormone replacement therapy.一项针对考虑绝经后激素替代疗法的女性的计算机化决策辅助工具与有声手册决策辅助工具的随机试验。
Patient Educ Couns. 2002 Jan;46(1):67-74. doi: 10.1016/s0738-3991(01)00167-7.
5
[Making a decision about hormone replacement therapy. A randomized controlled trial].[关于激素替代疗法的决策。一项随机对照试验]
Can Fam Physician. 2001 Aug;47:1586-93.
6
Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer.用于辅助早期乳腺癌女性辅助治疗决策的计算机程序。
J Clin Oncol. 2001 Feb 15;19(4):980-91. doi: 10.1200/JCO.2001.19.4.980.
7
A patient decision aid regarding antithrombotic therapy for stroke prevention in atrial fibrillation: a randomized controlled trial.一项关于心房颤动患者预防中风抗栓治疗的患者决策辅助工具:一项随机对照试验。
JAMA. 1999 Aug 25;282(8):737-43. doi: 10.1001/jama.282.8.737.
8
Randomized trial of a portable, self-administered decision aid for postmenopausal women considering long-term preventive hormone therapy.针对考虑长期预防性激素治疗的绝经后女性,开展一项便携式、自我管理决策辅助工具的随机试验。
Med Decis Making. 1998 Jul-Sep;18(3):295-303. doi: 10.1177/0272989X9801800307.
9
Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials.心房颤动患者中风的危险因素及抗血栓治疗的疗效。五项随机对照试验汇总数据的分析。
Arch Intern Med. 1994 Jul 11;154(13):1449-57.
10
How well can physicians estimate mortality in a medical intensive care unit?医生对医疗重症监护病房中的死亡率估计得有多准确?
Med Decis Making. 1989 Apr-Jun;9(2):125-32. doi: 10.1177/0272989X8900900207.